(Q44647010)

5 December 2017

title

Safety of nitrate withdrawal in angina-free and hemodynamically stable patients with coronary artery disease (English)

1 reference

5 December 2017

Safety of Nitrate Withdrawal in Angina-Free and Hemodynamically Stable Patients With Coronary Artery Disease * (English)

1 reference

https://api.crossref.org/works/10.1016/S0012-3692(15)33392-4

30 March 2024

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/S0012-3692(15)33392-4

30 March 2024

1

Jacob George

1 reference

5 December 2017

Ilan Kitzis

2

1 reference

5 December 2017

David Zandorf

3

1 reference

5 December 2017

Michal Golovner

4

1 reference

5 December 2017

Itzhak Shapira

5

1 reference

5 December 2017

Shlomo Laniado

6

1 reference

5 December 2017

Arie Roth

7

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

5 December 2017

http://journal.chestnet.org/article/S0012369216602787/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605030

https://api.elsevier.com/content/article/PII:S0012369215333924?httpAccept=text/xml

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0012-3692(15)33392-4

https://api.elsevier.com/content/article/PII:S0012369215333924?httpAccept=text/plain

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0012-3692(15)33392-4

30 March 2024

1 reference

5 December 2017

volume

124

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

1652-1657

1 reference

Nitrate therapy for stable angina pectoris

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

The L-arginine-nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Nitric oxide and cardiac function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Clinical aspects of nitrate tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Limited usefulness of intermittent nitroglycerin patches in stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Effect of intervals between doses on the development of tolerance to isosorbide dinitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Absence of pre-dose rebound phenomena with once daily 5-ISMN in a controlled-release formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2815%2933392-4

Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure

7 January 2021

11

1 reference

https://api.crossref.org/works/10.1016/S0012-3692(15)33392-4

Occupational habituation to aliphatic nitrates and the withdrawal hazards of coronary disease and hypertension

30 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/S0012-3692(15)33392-4

30 March 2024

Identifiers

1 reference

5 December 2017

1 reference